Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BBB Therapeutics B.V.
DescriptionPegylated liposomal doxorubicin conjugated with glutathione
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat brain metastases and primary brain tumors; Treat glioma
Regulatory Designation U.S. - Orphan Drug (Treat glioma);
EU - Orphan Drug (Treat glioma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today